IMMUCELL CORP /DE/ (ICCC) › Operating Cash FlowIMMUCELL CORP /DE/ (ICCC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$109.7K2010: -$808.6K2011: -$37.3K2012: $344.4K2013: $1.10M2014: $302.4K2015: $2.90M2016: -$222.3K2017: $1.18M2018: -$373.4K2019: $233.5K2020: $1.32M2021: $954.2K2022: -$1.54M2023: -$4.67M2024: $357.9K2025: $2.48M$2.48M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$2.48M+591.6%2024$357.9K+107.7%2023-$4.67M-202.8%2022-$1.54M-261.8%2021$954.2K-27.5%2020$1.32M+463.4%2019$233.5K+162.5%2018-$373.4K-131.8%2017$1.18M+628.9%2016-$222.3K-107.7%2015$2.90M+859.2%2014$302.4K-72.5%2013$1.10M+219.0%2012$344.4K+1022.9%2011-$37.3K+95.4%2010-$808.6K-637.3%2009-$109.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share